AI-assisted surgery removes brain tumor in world first for British patient

Patient Rhys Hibbert's eyesight was preserved through the AI-assisted procedure, allowing him to return to work post-surgery.
A millimeter in the wrong direction can erase everything
The precision required in brain surgery, where the AI system helped surgeons navigate with unprecedented accuracy.
Mark

What made this surgery different from what surgeons could do on their own?

Mimi

The AI could see and highlight structures in real time that are almost impossible to distinguish with the naked eye. In brain surgery, you're working in millimeters. One wrong move and you damage something critical. The AI color-coded everything—here's the tumor, here's the nerve controlling vision, here's the pathway you can't touch. It's like having a constantly updated map.

Mark

So the surgeon was still in control?

Mimi

Absolutely. The surgeon made every cut. The AI was there to show them what they were looking at and what to avoid. It's not the machine doing the surgery—it's the machine making the surgeon's judgment better.

Mark

Why does it matter that this AI was made in the UK?

Mimi

Because it shows that cutting-edge medical technology doesn't have to come from elsewhere. It was trained on hundreds of brain surgery videos, developed right there at UCL. That's a statement about where innovation can happen.

Mark

What happens to Rhys Hibbert now?

Mimi

He's back at work. His eyesight is intact. He was the first person in the world to have this done, and it worked. That's the real story—not just that it's possible, but that it actually preserved what mattered most to him.

Mark

Will other hospitals start doing this?

Mimi

That's the question everyone's asking. If it works this well, why wouldn't they? But these things take time. You need the technology, the training, the confidence. Right now, Hibbert is proof of concept. Everything else follows from that.

  • Every fraction of a millimeter inside the human brain carries the risk of erasing sight, speech, or memory — the surgical stakes could not have been higher.
  • The AI system shattered a longstanding limitation by color-coding microscopic nerve pathways and critical structures in real time, giving surgeons a living map of terrain previously navigated by instinct alone.
  • Crucially, the technology was not borrowed from abroad — it was built at UCL's Hawkes Institute and trained on hundreds of recorded surgeries, signaling that Britain is cultivating its own frontier in surgical AI.
  • The operation succeeded: the tumor was removed, Hibbert's eyesight was preserved, and he returned to work — proof of concept delivered in the most consequential arena imaginable.
  • The field is now asking not whether AI-assisted brain surgery works, but how rapidly it will expand into other neurological and surgical specialties worldwide.

In a London operating theatre this past May, a 48-year-old man named Rhys Hibbert became the first person in the world to have a brain tumor removed with the real-time guidance of artificial intelligence — a moment that quietly redrew the boundary between human skill and machine perception. The surgery, performed at the National Hospital for Neurology and Neurosurgery by a team from University College London, succeeded not by replacing the surgeon's hand but by illuminating what that hand could not otherwise see. It is a reminder that the most consequential revolutions in medicine often arrive not with fanfare, but with a scalpel held a millimeter more surely than before.

In May of this year, Rhys Hibbert arrived at the National Hospital for Neurology and Neurosurgery in London knowing he was about to become the first person in the world to undergo brain tumor removal guided by live artificial intelligence. At 48, the stakes surrounding him were as intimate as they were historic — a single misplaced cut inside the brain can cost a patient their vision, their speech, or their memory.

The AI system addressed one of neurosurgery's oldest challenges: distinguishing the tiniest, most critical structures buried within brain tissue. In real time, it color-coded nerve pathways controlling vision, mapped the tumor's boundaries, and continuously updated its picture of the surgical field — functioning, in effect, as a living minefield map that showed surgeons exactly where they could and could not cut.

What gave the moment additional weight was the origin of the technology. The system was not imported from Silicon Valley or Tokyo. It was developed in-house at UCL's Hawkes Institute, trained on hundreds of recorded brain surgeries by British researchers. Professor Hani Marcus, who led the procedure, made a point of noting this homegrown provenance.

The surgery succeeded on every measure that mattered. The tumor was removed, and Hibbert's eyesight — the very faculty the AI's precision was designed to protect — was preserved. He returned to work afterward, his life resuming its ordinary rhythm. When reflecting on the experience, he said he felt humbled to have been part of something that had never been attempted before.

AI had already entered UK operating rooms earlier in the year, when a Japanese-developed system assisted in a bowel resection at St Mark's Hospital. But Hibbert's case crossed a different threshold entirely — the brain, the most consequential organ a surgeon can touch, guided by a technology capable of seeing what human eyes alone cannot resolve. The question the medical world is now sitting with is not whether this works, but how soon it will become ordinary.

Rhys Hibbert walked into the National Hospital for Neurology and Neurosurgery in May knowing that surgeons would be attempting something no one had done before: removing a brain tumor with the help of live artificial intelligence guiding their hands. At 48, Hibbert became the first person in the world to undergo this kind of procedure. The stakes were as precise as they were high. A millimeter in the wrong direction inside the human brain can erase vision, movement, memory, or speech. The surgeons at the London hospital, part of University College London's NHS Foundation Trust, needed to see what they were doing with unprecedented clarity.

The artificial intelligence system did something surgeons have always struggled with: it identified the tiniest structures buried deep in brain tissue and color-coded them in real time. Nerves controlling vision appeared in one color. Critical pathways appeared in another. The tumor itself was marked for removal. As the surgical team worked, the AI continuously mapped the landscape of Hibbert's brain, showing them not just where the tumor was, but exactly which millimeters around it they could safely cut through and which ones they had to leave untouched. It was like having a constantly updating map of a minefield, with every danger zone illuminated.

What made this moment particularly significant for the British medical establishment was where the technology came from. The AI system was not imported from Silicon Valley or Japan. It was built in-house at UCL's Hawkes Institute, developed by researchers who had trained the system on hundreds of recorded brain surgeries. Professor Hani Marcus, the consultant neurosurgeon who led the procedure, emphasized this point: the innovation was homegrown, a product of British research and British hospitals.

The operation succeeded. Hibbert's tumor was removed. More importantly, his eyesight was preserved—the very thing the precision of the AI-assisted approach was designed to protect. He returned to work after surgery, his life resuming its ordinary shape. When asked about being the first person to undergo this procedure, Hibbert said he felt humbled to have been chosen for it, to have been part of something that had never been attempted before.

This was not the first time artificial intelligence had entered an operating room in the UK. In June, a different AI system called Eureka, developed in Japan, had been used to perform a bowel resection at St Mark's, the National Bowel Hospital. But Hibbert's case represented a different frontier: the brain, the most delicate and consequential organ to operate on, guided by technology that could see what human eyes alone could not distinguish. The question now is not whether AI-assisted surgery works—it does—but how quickly it will spread, and which other procedures will benefit from the same millimeter-perfect guidance.

Going a millimeter wrong can make a critical difference in brain surgery
— National Hospital for Neurology and Neurosurgery team
An important step, and the artificial intelligence used was homegrown in the UK
— Professor Hani Marcus, consultant neurosurgeon
Möchten Sie die ganze Geschichte? Das Original lesen bei Yahoo News Canada ↗
Kontakt FAQ